EX-2 3 microfs.htm FINANCIAL STATEMENTS Micromem Technologies Inc.: Financial Statements - Prepared by TNT Filings Inc.

 


MICROMEM TECHNOLOGIES INC.

Notice to Reader

The management of Micromem Technologies Inc. is responsible for the preparation of the accompanying interim financial statements. The interim financial statements have been prepared in accordance with accounting principles generally accepted in Canada and are considered by management to present fairly the financial position, operating results and cash flows of the Company.

These interim financial statements have not been reviewed by an auditor. These interim financial statements are unaudited and include all adjustments, consisting of normal and recurring items, that management considers necessary for a fair presentation of the consolidated financial position, results of operations and cash flows.

 

"Joseph Fuda"
(signed) Joseph Fuda, President and CEO
 
 
 
"Dan Amadori"
(signed) Dan Amadori, Chief Financial Officer

 


MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)

Consolidated Balance Sheet
(Expressed in United States dollars)

As at,        
    July 31, 2004   October 31, 2003
    [Unaudited]   [Audited]
         
Assets        
Current assets:        
     Cash and cash equivalents $ 285,272 $ 79,233
     Term Deposits   79,366   219,930
     Deposits and other receivables   111,680   47,207
    476,318   346,370
Capital assets   2,539   3,768
Patents and trademarks   -   -
Royalty rights   -   -
    478,857   350,138
         
Liabilities and Shareholders' Equity        
Current liabilities:        
     Accounts payable and accrued liabilities   234,458   245,700
         
Shareholders' equity:        
     Share capital:        
          Authorized:        
              2,000,000 special preference shares, redeemable, voting        
              Unlimited common shares without par value        
           Issued and outstanding:        
              55,332,187 common shares (2003 - 48,732,187)   31,879,287   31,236,287
     Contributed surplus   578,891   578,891
     Deficit accumulated during the development stage   (32,213,779)   (31,710,740)
    244,399   104,438
         
  $ 478,857 $ 350,138
         
See accompanying notes to consolidated financial statements.        

MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)

Consolidated Statements of Operations and Deficit
(Expressed in United States dollars)

                  Period from
For the,                 September 3, 1997 to
  three-month period ended July 31,   nine-month period ended July 31, July 31,2004
                     
    2004   2003   2004   2003    
    [unaudited]   [unaudited]   [unaudited]   [unaudited]   [unaudited]
Revenue:                    
     Interest and other income $ 450 $ 642 $ 4,629 $ 17,085 $ 531,267
                     
Costs and expenses (income):                    
     Administration   74,971   60,587   113,576   144,927   2,105,761
     Professional fees   98,120   25,198   121,762   70,063   2,819,357
     Wages and salaries   1,233   24,729   46,658   106,475   9,384,269
     Research and development   36,520   25,197   160,163   434,319   6,176,445
     Travel and entertainment   25,347   4,052   35,092   7,510   1,025,058
     Amortization of patents and trademarks   -   9,127   -   27,176   67,596
     Amortization of capital assets   130   3,136   3,990   33,741   340,121
     Operating Leases   -   -   -   -   109,412
     Loss on Sale of Investment   -   -   -   -   54,606
     Write-down of Investment   -   -   -   -   61,020
     Write-down of Royalty Rights   -   -   -   -   10,000,000
     Write-down of Patents and Trademark   -   -   -   -   299,820
     Fees to Related Parties   -   -   -   -   65,460
     Interest Expense   -   -   -   -   186,000
     Loss on sale of assets   -   -   -   58,302   75,027
     Unrealized foreign exchange loss (gain)   3,998   13,877   26,427   (57,966)   (44,583)
    240,319   165,903   507,668   824,547   32,725,369
                     
Loss before Income Taxes $ (239,869) $ (165,261) $ (503,039) $ (807,462) $ (32,194,102)
                     
Provision for (recovery of) Income Taxes Current -   -   -   -   19,677
                     
Net loss for the period $ (239,869) $ (165,261) $ (503,039) $ (807,462)   (32,213,779)
                     
Deficit accumulated during the                    
development stage, beginning of period   (31,973,910)   (30,902,976)   (31,710,740)   (30,260,775)   -
Deficit accumulated during the                    
development stage, end of period $ (32,213,779) $ (31,068,237) $ (32,213,779) $ (31,068,237) $ (32,213,779)
                     
                     
Loss per share - basic and diluted $ (0.004) $ (0.004) $ (0.009) $ (0.017) $ (0.738)
                     
Weighted average number of shares   53,878,383   46,700,937   53,878,383   46,700,937   43,630,085
                     
See accompanying notes to consolidated financial statements.

MICROMEM TECHNOLOGIES INC.
(A DEVELOPMENT STAGE COMPANY)

Consolidated Statement of Cash Flows
(Expressed in United States dollars)

                    Period from
For the,                 September 3,1997 to
    three-month period ended July 31,   nine-month period ended July 31,   July 31,2004
                     
    2004   2003   2004   2003    
    [unaudited]   [unaudited]   [unaudited]   [unaudited]   [unaudited]
                     
Cash flows from operating activities:                    
   Net loss for the period $ (239,869) $ (165,261) $ (503,039) $ (807,462) $ (32,213,779)
   Adjustments to reconcile loss for                    
   the period to net cash used in operating activities:                    
       Amortization of patents and trademarks   -   9,127   -   27,176   67,596
       Amortization of capital assets   130   3,136   3,990   33,741   525,341
       Loss on Sale of Investment   -   -   -   58,302   49,810
       Write down of Investment   -   -   -   -   61,020
       Loss on disposal of capital assets   -   -   -   -   65,460
       Write-down of Royalty Rights   -   -   -   -   10,000,000
       Write-down of Patents and Trademark   -   -   -   -   299,820
       Share compensation expense   -   -   -   -   7,285,696
       Non-cash wages and salaries   -   -   -   -   34,000
   Change in non-cash working capital items,   -   -   -   -   -
       Decrease (increase) in deposits and other receivables   (1,872)   26,312   (64,473)   111,419   (103,083)
       Increase (decrease) in accounts payable and accrued liabilities   37,488   (69,599)   (11,242)   (149,653)   128,414
Net cash used in operating activities   (204,123)   (196,285)   (574,764)   (726,477)   (13,799,705)
                     
Cash flows from investing activities:                    
     Capital assets, net   (1,652)   -   (2,761)   1,962   (727,798)
     Proceed on disposal of capital assets               (1,688)   134,458
     Patents and trademarks   -   (1,271)   -   (23,235)   (367,416)
     Sale of available-for-sale Investment                   260,641
     Royalty Rights                   (2,000,000)
     Term Deposits   (2,464)   -   140,564   -   (79,366)
Net cash provided by (used in) investing activities   (4,116)   (1,271)   137,803   (22,961)   (2,779,481)
                     
                     
Cash flows from financing activities:                    
     Issue of common shares   365,000   -   643,000   -   16,283,733
     Net Proceeds from Shareholder's Loan                   544,891
     Loan Proceeds from Avanticorp International Inc.                   112,031
     Rights issue Costs                   (76,197)
Net cash provided by (used in) financing activities   365,000   -   643,000   -   16,864,458
                     
Increase (decrease) in cash and cash equivalents   156,761   (197,556)   206,039   (749,438)   285,272
                    -
Cash and cash equivalents, beginning of period   128,511   432,057   79,233   983,939   -
                    -
Cash and cash equivalents, end of period $ 285,272 $ 234,501 $ 285,272 $ 234,501 $ 285,272
                     
Supplemental cash flow information:           -        
     Interest paid   -   -           76,987
     Income taxes paid   -   -           66,722
                     
See accompanying notes to consolidated financial statements.

Micromem Technologies Inc.
(A development stage company)

Supplemental Notes to the Consolidated Financial Statements

For the nine months period ended July 31, 2004

1. Going Concern:

The consolidated financial statements have been prepared on the "going concern" basis, which presumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

The Company has incurred substantial losses in its development stage. It will be necessary to raise additional funds for the continuing development, testing and commercial exploitation of its technologies. The sources of these funds have not yet been identified and there can be no certainty that sources will be available in the future.

The Company's ability to continue as a going concern is dependent upon completing the development of its technology for a particular application, achieving profitable operations, obtaining additional financing and successfully brining its technologies to the market. The outcome of these matters cannot be predicted at this time. The consolidated financial statements have been prepared on a going concern basis and do not include any adjustments to the amounts and classifications of the assets and liabilities that might be necessary should the Company be unable to continue in business.

2. Summary of significant accounting policies:

These consolidated financial statements have been prepared in accordance with Canadian GAAP and are stated in United States dollars. The interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended October 31, 2003 and the Management's Discussion and Analysis for the 9 months ending July 31, 2004. The accounting policies used in the preparation of these interim consolidated financial statements are consistent with the accounting policies used in the company's year end audited consolidated financial statements of October 31,2003.